Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-13 4:37 pm Unchanged |
2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Macro Fund LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2023-02-08 06:07 am Purchase |
2022-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Mitchell P. Kopin | 19,197 9.000% |
19,197 (New Position) |
Filing History |
| 2022-08-05 5:23 pm Purchase |
2022-07-26 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 10,185 9.900% |
8,979 (+744.27%) |
Filing History |
| 2022-08-01 06:06 am Purchase |
2022-07-26 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Mitchell P. Kopin | 9,633 9.990% |
9,633 (New Position) |
Filing History |
| 2022-07-28 5:09 pm Purchase |
2022-07-26 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lincoln Park Capital Fund LLC | 9,112 9.990% |
9,112 (New Position) |
Filing History |
| 2022-02-14 6:19 pm Purchase |
2021-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Armistice Capital, LLC | 5,920 14.400% |
5,920 (New Position) |
Filing History |
| 2022-02-11 5:07 pm Purchase |
2021-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Lind Global Fund II LP | 1,206 3.300% |
1,206 (New Position) |
Filing History |
| 2022-01-27 4:48 pm Purchase |
2021-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
BIGGER CAPITAL FUND L P | 1,206 3.300% |
1,206 (New Position) |
Filing History |
| 2022-01-24 10:33 am Purchase |
2021-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX |
Empery Asset Management, LP | 1,484 4.050% |
1,484 (New Position) |
Filing History |
| 2021-08-20 4:45 pm Purchase |
2021-08-11 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
Lind Global Fund II LP | 1,302,933 9.900% |
1,302,933 (New Position) |
Filing History |
| 2021-08-20 4:40 pm Purchase |
2021-08-09 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
Empery Asset Management, LP | 868,622 6.880% |
868,622 (New Position) |
Filing History |
| 2021-08-19 4:30 pm Purchase |
2021-08-09 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
BIGGER CAPITAL FUND L P | 797,213 6.300% |
797,213 (New Position) |
Filing History |
| 2021-08-18 4:17 pm Purchase |
2021-08-09 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
Mitchell P. Kopin | 460,978 3.500% |
460,978 (New Position) |
Filing History |
| 2021-08-17 4:45 pm Purchase |
2021-08-11 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
Lind Global Macro Fund LP | 1,302,933 9.900% |
1,302,933 (New Position) |
Filing History |
| 2021-08-13 4:01 pm Unchanged |
2021-08-13 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
Armistice Capital, LLC | 2,916,101 19.800% |
0 (Unchanged) |
Filing History |
| 2021-08-03 5:04 pm Sale |
2021-07-27 | 13D | EyeGate Pharmaceuticals, Inc. EYEG |
Armistice Capital, LLC | 2,916,101 28.900% |
-1,883,000 (-39.24%) |
Filing History |
| 2021-02-09 2:53 pm Sale |
2020-12-31 | 13G | EyeGate Pharmaceuticals, Inc. EYEG |
Hudson Bay Capital Management LP | 0 0.000% |
-328,192 (Position Closed) |
Filing History |
| 2021-01-12 5:08 pm Purchase |
2021-01-06 | 13D | EyeGate Pharmaceuticals, Inc. EYEG |
Armistice Capital, LLC | 4,799,101 56.200% |
1,554,101 (+47.89%) |
Filing History |